Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug-drug ...
Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...
Researchers developed DDINet, a deep learning model that predicts drug–drug interactions and their biological effects. The system performed well with unseen drugs and may improve safety in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results